Edaravone in the Treatment of Aquaporin-4 Antibody-positive Optic Neuritis

See also
Status	Clinical Trial	Phase
Unknown status	`NCT00261326` - Simvastatin Treatment of Patients With Acute Optic Neuritis	Phase 3
Recruiting	`NCT03963310` - Optical Coherence Tomography and Optic Neuritis Not Related to Multiple Sclerosis
Recruiting	`NCT03586557` - Effectiveness of Plasma Exchange in Treating With Severe Acute AQP4-Ab Positive Optic Neuritis	N/A
Recruiting	`NCT05487989` - VIsual Pathways Model in Neuro-inflammatory Disorders
Terminated	`NCT04131764` - Diagnosis of ON With or Without MS or NMOSD
Completed	`NCT01962571` - Treatment of Optic Neuritis With Erythropoietin: a Randomised, Double-blind, Placebo-controlled Trial	Phase 3
Recruiting	`NCT03302585` - High-Dose Vitamin D Induction in Optic Neuritis	Phase 2
Recruiting	`NCT02886377` - The Correlation Between AQP-4 Ab and the Visual Function of Patients With Demyelinating ON at Onset	N/A
Completed	`NCT01987167` - Defining the Functional and Neuro-Protective Potential of ACTHAR in Acute Optic Neuritis	Early Phase 1
Completed	`NCT01451593` - Neuroprotection With Phenytoin in Optic Neuritis	Phase 2
Completed	`NCT03630497` - BN201 SAD MAD Study in Healthy Subjects	Phase 1
Completed	`NCT01337986` - Ampyra for Optic Neuritis in Multiple Sclerosis	Phase 2/Phase 3
Completed	`NCT01274702` - Visual Reconstitution Therapy After Optic Neuritis	Phase 2
Active, not recruiting	`NCT00445367` - Biobank For MS And Other Demyelinating Diseases
Withdrawn	`NCT00037115` - Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event.	Phase 4
Not yet recruiting	`NCT06389968` - Light Stimulation to Improve Visual Function After Optic Neuritis in Persons With Multiple Sclerosis	N/A
Recruiting	`NCT04257734` - Epidemiologic and Clinical Characteristics of Optic Neuritis in China
Completed	`NCT03753893` - Ocular Manifestations in Rheumatic Diseases
Completed	`NCT02939937` - Effect of Phenytoin on the Ganglion Cell Layer in Patients With Optic Neuritis	Phase 2
Recruiting	`NCT04148781` - Fampridine-SR and Optic Neuritis Recovery	Early Phase 1

NCT number	NCT05540262
Study type	Interventional
Source	First Affiliated Hospital of Guangxi Medical University
Contact
Status	Recruiting
Phase	N/A
Start date	January 15, 2022
Completion date	December 31, 2024

Edaravone in the Treatment of Aquaporin-4 Antibody-positive Optic Neuritis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms